EPM's Lu Rahman looks at the UK pharma sector and its uncertain relationship with Europe.
The debate around Brexit and its impact on the European economy isn’t showing any signs dying down. As might be expected, from one day to the next we have conflicting output about the on-going effect of the UK’s decision to leave the EU – and the pharmaceutical sector is an integral part of this conversation.